<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032021000100040</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Paratiroidectomía por hiperparatiroidismo en una serie de pacientes mexicanos: características clínicas y demográficas, nuestra experiencia]]></article-title>
<article-title xml:lang="en"><![CDATA[Parathyroidectomy for hyperparathyroidism in a serie of Mexican patients: clinical and demographic characteristics, our experience]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Boyer Duck]]></surname>
<given-names><![CDATA[Estefanía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cortés Romano]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Gómez]]></surname>
<given-names><![CDATA[Adriana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espinosa Lira]]></surname>
<given-names><![CDATA[Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad La Salle Facultad Mexicana de Medicina ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Ángeles Pedregal Departamento de Cirugía General ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Ángeles Pedregal Departamento de Patología ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<volume>19</volume>
<numero>1</numero>
<fpage>40</fpage>
<lpage>44</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032021000100040&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032021000100040&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032021000100040&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  El hiperparatiroidismo primario (HPP) es la tercera alteración endócrina más frecuente en el mundo, con una prevalencia estimada de 1% en mayores de 65 años. Caracterizada por presencia de niveles elevados de calcio y de paratohormona (PTH). El objetivo de este estudio retrospectivo es describir características clínicas y demográficas de casos con HPP sometidos a paratiroidectomía en hospital privado de tercer nivel en la Ciudad de México.  Material y métodos:  Estudio retrospectivo de una serie de pacientes con HPP sometidos a paratiroidectomía, por diferentes cirujanos, periodo de enero de 2015 a diciembre de 2018. Incluyendo 31 pacientes, se obtuvo la base del Servicio de Patología y posteriormente se buscaron los expedientes. Se buscaron datos clínicos, demográficos, laboratorio y de cirugía.  Resultados:  La media de edad de población estudiada fue de 56.48 años (DE ± 13.7); 24 (77.41%) fueron mujeres. Causa principal fue adenoma. En el análisis multivariado de regresión logística, los factores de riesgo independientes para duración de cirugía mayor a 60 minutos fueron hipertensión y dislipidemia, todos los pacientes consiguieron normocalcemia, sin existir complicaciones transquirúrgicas o postquirúrgicas.  Conclusiones:  La hipertensión y dislipidemia se identificaron como factores de riesgo independientes para mayor duración (&gt; 60 minutos) de paratiroidectomía. La paratiroidectomía es curativa en manos expertas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Primary hyperparathyroidism (PPH) is the third most frequent endocrine disorder in the world with an estimated prevalence of 1% in people over 65 years. It is characterized by the presence of elevated calcium levels and elevated levels of paratohormone (PTH). The objective of this retrospective study is to describe clinical and demographic characteristics of patients with PPH, who had parathyroidectomy in a third level private hospital in Mexico City.  Material and methods:  Retrospective study of a group of patients diagnosed with PPH who had parathyroidectomy, by different surgeons, period from January 2015 to December 2018. We included 31 patients of which the data was obtained from pathology service; clinical, demographic, laboratory and surgery data were recorded.  Results:  The average age of the study population was 56.48 years (SD ± 13.7), 24 (77.41%) were women. Main cause was adenoma. In the multivariate logistic regression analysis, the independent risk factors for the duration of surgery greater than 60 minutes were hypertension and dyslipidemia, all patients achieved normocalcemia, without there being any trans-surgical or post-surgical complications.  Conclusions:  Hypertension and dyslipidemia are identified as independent risk factors for longer duration (&gt; 60 minutes) for parathyroidectomy. Parathyroidectomy is a curative procedure in expert hands.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Hiperparatiroidismo primario]]></kwd>
<kwd lng="es"><![CDATA[paratiroidectomía]]></kwd>
<kwd lng="es"><![CDATA[hipercalcemia]]></kwd>
<kwd lng="es"><![CDATA[hipertensión]]></kwd>
<kwd lng="es"><![CDATA[dislipidemia]]></kwd>
<kwd lng="en"><![CDATA[Primary hyperparathyroidism]]></kwd>
<kwd lng="en"><![CDATA[parathyroidectomy]]></kwd>
<kwd lng="en"><![CDATA[hypercalcemia]]></kwd>
<kwd lng="en"><![CDATA[hypertension]]></kwd>
<kwd lng="en"><![CDATA[dyslipidemia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Donnan]]></surname>
<given-names><![CDATA[PT]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Leese]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK]]></article-title>
<source><![CDATA[Clin Endocrinol (Oxf)]]></source>
<year>2009</year>
<volume>71</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>485-93</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fraser]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperparathyroidism]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2009</year>
<volume>374</volume>
<numero>9684</numero>
<issue>9684</issue>
<page-range>145-58</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gasser]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy]]></article-title>
<source><![CDATA[Wien Med Wochenschr]]></source>
<year>2013</year>
<volume>163</volume>
<numero>17-18</numero>
<issue>17-18</issue>
<page-range>397-402</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bilezikian]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Bandeira]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cusano]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperparathyroidism]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2018</year>
<volume>391</volume>
<numero>10116</numero>
<issue>10116</issue>
<page-range>168-78</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Hanley]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzoli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bollerslev]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Rejnmark]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus]]></article-title>
<source><![CDATA[Osteoporos Int]]></source>
<year>2017</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-19</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical management of primary hyperparathyroidism]]></article-title>
<source><![CDATA[J Clin Densitom]]></source>
<year>2013</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>60-3</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pallan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of primary hyperparathyroidism]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2012</year>
<volume>344</volume>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Granados Canseco]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Servín Torres]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Piscil Salazar]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Velázquez García]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano Galeana]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Granados Canseco]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiencia quirúrgica en el hiperparatiroidismo primario en el Hospital de Especialidades del Centro Médico Nacional &#8220;La Raza&#8221;]]></article-title>
<source><![CDATA[Cir Gen]]></source>
<year>2012</year>
<volume>34</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>249-53</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Udelsman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Akerstrom]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Biagini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Duh]]></surname>
<given-names><![CDATA[QY]]></given-names>
</name>
<name>
<surname><![CDATA[Miccoli]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Niederle]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2014</year>
<volume>99</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3595-606</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Komaba]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Kakuta]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Fukagawa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of secondary hyperparathyroidism: how and why?]]></article-title>
<source><![CDATA[Clin Exp Nephrol]]></source>
<year>2017</year>
<volume>21</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>37-45</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Concistre]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Grillo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[La Torre]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Carretta]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fabris]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Petramala]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism]]></article-title>
<source><![CDATA[Endocrine]]></source>
<year>2018</year>
<volume>60</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>129-37</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
